Our results showed that caregiving burden was negatively associated with the sense of ability.. 3 key findings →
Design: cross-sectional Participants: 355 Evidence: low
Full summary, score breakdown and related studies → Original source
Research
27,780 Alzheimer's and dementia studies in plain English, each scored out of 100.
This interdisciplinary, prototype-centered AI education program was associated with significant short-term improvements in students’ perceived AI knowledge, digital mental health readiness, interdisciplinary collaboration, innovation capacity, STEM career readiness, and solution-design ability. 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Caregiver narratives were predominantly negative (89.3% of posts; mean valence - 0.46), with interpretable structure. 2 key findings →
Design: longitudinal study Participants: 7,198 Evidence: moderate
Full summary, score breakdown and related studies → Original source
The culturally adapted CSP enhanced self-efficacy among Chinese Australian carers of people with dementia, but not carer burden, quality of life and approach to dementia care. 3 key findings →
Participants: 48 Evidence: low
Full summary, score breakdown and related studies → Original source
Four main themes emerged from the data: 1) the unseen challenges of caregiving; 2) knowledge and experiences lead to stronger self-confidence; 3) the power of peer influence on caregiving; and 4) pursuing better support for carers. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Although caregivers demonstrated resilience and adaptive coping, YOD caregiving in Singapore remained constrained by limited access to visible, tailored, and age-appropriate support. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Caregiving for older adults with dementia in Northern Ethiopia is a totalizing and demanding experience that profoundly affects caregivers’ lives. 2 key findings →
Participants: 25 Evidence: low
Full summary, score breakdown and related studies → Original source
Family physicians' empathy levels were independently associated with general, supportive, and accepting attitudes toward people with dementia, but not with exclusionary attitudes. 5 key findings →
Design: cross-sectional Participants: 412 Evidence: low
Full summary, score breakdown and related studies → Original source
Internet use for health information was significantly associated with Alzheimer’s disease diagnosis. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The prognostic significance of psychosis in dementia differs by symptom profile. 4 key findings →
Participants: 21,108 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Functional decline, as assessed by CGA, was more prominent in patients undergoing hemodialysis than in those not undergoing hemodialysis. 3 key findings →
Participants: 328 Evidence: low
Full summary, score breakdown and related studies → Original source
Recent mechanistic evidence identifies lithium deficiency as a driver of Alzheimer’s disease and related dementias (ADRD) pathogenesis. 4 key findings →
Evidence: high
Full summary, score breakdown and related studies → Original source
16/100
More than one-quarter of residents with ADRD remain untreated with guideline-recommended pharmacotherapy, and treatment varied significantly by non-clinical predictors. 5 key findings →
Participants: 359,801 Evidence: low
Full summary, score breakdown and related studies → Original source
Real-terms UK government spending on health-related long-term care grew by £6.4 billion (22.9%) between 2013 and 2022, from £27.9 to £34.3 billion. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Oral health is a key component of quality of life among older adults, yet maintaining preventive dental care becomes increasingly difficult for those with long-term care (LTC) needs. 4 key findings →
Participants: 1,055 Evidence: low
Full summary, score breakdown and related studies → Original source
Overall, 81.7% of residents diagnosed with depression had ≥1 pharmacological depression treatment order. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The multifactorial interventions implemented in community settings showed no effect on dementia onset or health outcomes. 5 key findings →
Participants: 256 Evidence: low
Full summary, score breakdown and related studies → Original source
Passive sleep monitoring identified physiologically interpretable sleep markers associated with next-day agitation occurrence, supporting prospective evaluation of under-mattress sensing as a source of short-term risk information for dementia care. 4 key findings →
Participants: 55 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Contexts and mechanisms associated with attendees’ and caregivers’ social determinants of health, and system-level contexts and mechanisms that influence ADPs are important knowledge gaps to be addressed by studies and to be incorporated in our program theory in the future. 3 key findings →
Participants: 17 Evidence: low
Full summary, score breakdown and related studies → Original source
16/100
Strengths and limitations of this study This study evaluates a digitally enabled remote monitoring model for people living with dementia that integrates passive in-home sensors and algorithm-derived digital biomarkers to detect clinically relevant changes such as infection risk, behavioural disturbance and physiological deterioration. 5 key findings →
Participants: 100 Evidence: high
Full summary, score breakdown and related studies → Original source
Among adults with ADRD, high SDM was associated with greater ACP prevalence in unadjusted analyses, although the fully adjusted association was not statistically significant. 5 key findings →
Participants: 3,635 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Two analytical themes were identified: (1) challenges in preserving the person's voice throughout the dementia trajectory, reflecting a shift toward caregiver-mediated decision-making, assumptions about capacity, and delayed ACP initiation; and (2) challenges in maintaining continuity of expressed values and preferences over time, reflecting uncertainty about future care needs and the limitations of one-time ACP conversations. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The increasing prevalence of Alzheimer’s disease (AD) underscores the need for care models that preserve identity, autonomy, and comfort throughout disease progression. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
After more than three decades of intensive research, Alzheimer disease care remains largely palliative, and the field has drawn sustained criticism, both for that reason and for pursuing some directions of inquiry over others. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
We found that 75% of participants would choose for their life to end in the early stages of ADRD. 4 key findings →
Participants: 1,015 Evidence: low
Full summary, score breakdown and related studies → Original source
Where “Free full text” comes from
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled. Show only studies that are free to read
How the 0–100 score works — and why some entries are capped
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
- Journal tier up to 10 pts
- Journal's citation record up to 4 pts
- Study design up to 12 pts
- Strength of evidence up to 5 pts
- Peer-review validation up to 10 pts
- How recent up to 5 pts
- Sample size up to 4 pts
- Effect reported up to 3 pts
- Studied in people up to 3 pts
- Randomised / blinded up to 2 pts
- Times cited up to 7 pts
- Citations per year up to 5 pts
- Impact for its field and year up to 6 pts
- Cited by studies here up to 6 pts
- Still being cited up to 4 pts
- Senior author's track record up to 4 pts
- Institution's track record up to 3 pts
- Multi-centre collaboration up to 3 pts
- Indexed in PubMed up to 2 pts
- Free to read up to 2 pts
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 27,780 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
What this library is — and isn't
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 27,780 records, built mostly from automated pulls of Europe PMC (61.1% of the library) and OpenAlex (18.3%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,034 records (3.7% of the library) are not peer-reviewed — 962 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →